MedTrace Logo

Hybrid Staged Operating Room and Interventional Catheter Ablation for Atrial Fibrillation

NCT01622907 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-06-19

No results posted yet for this study

Summary

Prospective, multi-center, investigator-driven trial. This study hypothesizes that combining surgical endoscopic and transcatheter techniques in a staged fashion provides superior clinical outcomes than isolated surgical/EP approaches in patients with persistent AF lasting \> 1 year but \> 5 years.

The proposed procedure involves the creation of cardiac lesions with epicardially applied radiofrequency (RF) ablation through a minimally invasive surgical (MIS) approach followed by a delayed EP ablation procedure performed at 1-2 months from the surgical operation.

Conditions

Sponsors & Collaborators

  • Meditrial SrL

    collaborator INDUSTRY

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    lead OTHER

Principal Investigators

  • CLAUDIO MUNERETTO, PROF. · UNIV. HOSP. SPEDALI CIVILI

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-04-30
Completion
2015-04-30

Countries

  • France
  • Germany
  • Italy
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01622907 on ClinicalTrials.gov